|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 220.98 USD | -1.18% |
|
+1.41% | +12.53% |
| Dec. 15 | Barclays Adjusts PT on IQVIA Holdings to $230 From $200, Maintains Equalweight Rating | MT |
| Dec. 10 | Glenmark Pharmaceuticals to Launch Leucovorin Calcium for Injection | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 31.48x | 6x | 3.18x | 13.71x | 21.49x | 38.08B | ||
| 0.94% | 1.07% | 36.62x | 3.75x | 5.32x | 17.81x | 26.04x | 46.18B | ||
| -.--% | -.--% | 99.81x | 8.6x | 6.06x | 60.82x | 94.07x | 34.38B | ||
| 0.39% | 0.42% | 52.75x | 2.34x | 10.17x | 28.77x | 37.41x | 27.99B | ||
| -.--% | -.--% | 37.77x | 37.71x | 6.11x | 27.77x | 29.09x | 15.75B | ||
| -.--% | -.--% | -14.14x | 9.62x | 5519.7x | -13.33x | -13.17x | 15.27B | ||
| -.--% | -.--% | 28.54x | 1.51x | 2.12x | 10.82x | 12.04x | 14.08B | ||
| -.--% | -.--% | -54.42x | 1394.75x | 15.29x | -125.32x | -88.92x | 13.03B | ||
| -.--% | -.--% | -35.51x | 46.92x | 13.39x | -38.25x | -33.63x | 12.92B | ||
| -.--% | -.--% | -46.5x | 23.89x | 10.15x | 36168.69x | -188.4x | 12.22B | ||
| 1.09% | 1.2% | 22.86x | 2x | 1.91x | 8.69x | 13.31x | 12.13B | ||
| 0.33% | 0.26% | 24.01x | 2.59x | 4.88x | 13.19x | 16.47x | 9.85B | ||
| -.--% | -.--% | 47.25x | 2.77x | 2.92x | 12.09x | 14.74x | 9.75B | ||
| 0.55% | 0.55% | 45.73x | 4.21x | 7.42x | 20.95x | 22.84x | 9.14B | ||
| -.--% | -.--% | -24.51x | 7.41x | 112.2x | -19.3x | -17.99x | 6.85B | ||
| 0.71% | 0.88% | 29.28x | 3.39x | 3.59x | 14.81x | 23.28x | 6.85B | ||
| -.--% | -.--% | -21.14x | 7.31x | 23849.49x | -20.53x | -19.85x | 6.91B | ||
| Average | 0.24% | 0.26% | 15.29x | 92.04x | 1,739.64x | 2,128.32x | -3.01x | 17.14B | |
| Weighted average by Cap. | 0.28% | 0.31% | 27.87x | 71.50x | 863.41x | 1,526.28x | 11.70x |
- Stock Market
- Equities
- IQV Stock
- Sector Iqvia Holdings Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















